{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T20:20:34Z","timestamp":1768162834570,"version":"3.49.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1765,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Terlipressin is frequently used in acute variceal bleeding due to its powerful effect on vasopressin V1 receptors. Although terlipressin is also a partial agonist of renal vasopressin V2 receptors, its effects on serum sodium concentration have not been specifically investigated. To examine the effects of terlipressin on serum sodium concentration in patients with acute portal-hypertensive bleeding, 58 consecutive patients with severe portal-hypertensive bleeding treated with terlipressin were investigated. In the whole population, serum sodium decreased from 134.9 \u00b1 6.6 mEq\/L to 130.5 \u00b1 7.7 mEq\/L (<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.002). Thirty-nine patients (67%) had a decrease in serum sodium \u2265 5 mEq\/L during treatment: in 18 patients (31%), between 5 and 10 mEq\/L and in 21 patients (36%), greater than 10 mEq\/L. In this latter group, serum sodium decreased from 137.2 \u00b1 5 to 120.5 \u00b1 5 mEq\/L (<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>&lt; 0.001). In multivariate analysis, the reduction in serum sodium was related to baseline serum sodium and Model for End-Stage Liver Disease (MELD) score; patients with low MELD and normal or near-normal baseline serum sodium had the highest risk of hyponatremia. Serum sodium returned to baseline values in most patients shortly after cessation of therapy. Three of the 21 patients with marked reduction in serum sodium developed neurological manifestations, including osmotic demyelination syndrome in one patient due to a rapid recovery of serum sodium (serum sodium in these three patients decreased from 135, 130, and 136 to 117, 114, and 109 mEq\/L, respectively).<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>\n                                 <jats:bold>An acute reduction in serum sodium concentration is common during treatment with terlipressin for severe portal-hypertensive bleeding. It develops rapidly after start of therapy, may be severe in some patients and is associated with neurological complications, and is usually reversible after terlipressin withdrawal. (Hepatology 2010<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.23893","type":"journal-article","created":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T23:30:29Z","timestamp":1281051029000},"page":"1783-1790","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":90,"title":["Hyponatremia in Patients Treated With Terlipressin for Severe Gastrointestinal Bleeding Due to Portal Hypertension"],"prefix":"10.1097","volume":"52","author":[{"given":"Elsa","family":"Sol\u00e0","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabela","family":"Lens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Mart\u00edn-Llah\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Fagundes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Pavesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Gonz\u00e1lez-Abraldes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angels","family":"Escorsell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Mas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaume","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pere","family":"Gin\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-28-20250312","doi-asserted-by":"crossref","first-page":"823832","DOI":"10.1056\/NEJMra0901512","article-title":"Management of varices and variceal hemorrhage in cirrhosis.","volume":"362","author":"Garcia Tsao","year":"2010","journal-title":"N Engl J Med"},{"key":"R2-28-20250312","first-page":"18021829","article-title":"Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the department of veterans affairs hepatitis C resource center program and the national hepatitis C program.","volume":"104","author":"Garcia Tsao","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R3-28-20250312","first-page":"167176","article-title":"Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.","volume":"43","author":"De Franchis","year":"2005","journal-title":"J Hepatol"},{"key":"R4-28-20250312","first-page":"922938","article-title":"Carey W; the Practice Guideline Committee of the American Association for the Study of Liver Diseases, the Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.","volume":"46","author":"GarciaTsao","year":"2007","journal-title":"Hepatology"},{"key":"R5-28-20250312","doi-asserted-by":"crossref","first-page":"621627","DOI":"10.1016\/S0168-8278(97)80428-X","article-title":"Time profiling of the haemodynamic effects of terlipressin in portal hypertension.","volume":"26","author":"Escorsell","year":"1997","journal-title":"J Hepatol"},{"key":"R6-28-20250312","doi-asserted-by":"crossref","first-page":"11031109","DOI":"10.1007\/BF01535785","article-title":"Hemodynamic changes of systemic, hepatic and splenic circulation following triglycyllysinvasopressin administration in alcoholic cirrhosis.","volume":"33","author":"Merkel","year":"1988","journal-title":"Dig Dis Sci"},{"key":"R7-28-20250312","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1034\/j.1600-0676.2000.020001051.x","article-title":"Central and systemic haemodynamic effects of terlipressin in portal hypertension patients.","volume":"20","author":"Moller","year":"2000","journal-title":"Liver"},{"key":"R8-28-20250312","first-page":"121127","article-title":"Antidiuretic activity of terlipressin (triglycyllysine vasopressin) role of pressure natriuresis.","volume":"41","author":"Machova","year":"1992","journal-title":"Physiol Res"},{"key":"R9-28-20250312","doi-asserted-by":"crossref","first-page":"F1295F1300","DOI":"10.1152\/ajprenal.90407.2008","article-title":"Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects.","volume":"295","author":"Krag","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"R10-28-20250312","doi-asserted-by":"crossref","first-page":"471476","DOI":"10.1053\/jhep.2000.16601","article-title":"Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study.","volume":"32","author":"Escorsell","year":"2000","journal-title":"Hepatology"},{"key":"R11-28-20250312","doi-asserted-by":"crossref","first-page":"12911299","DOI":"10.1053\/gast.1996.v111.pm8898643","article-title":"Bosch J, members of the variceal bleeding study group. Doubleblind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage.","volume":"111","author":"Feu","year":"1996","journal-title":"Gastroenterology"},{"key":"R12-28-20250312","first-page":"5364","article-title":"Systematic review: Terlipressin in acute oesophageal variceal haemorrhage.","volume":"17","author":"Iannou","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R13-28-20250312","first-page":"390394","article-title":"Doubleblind randomized multicenter study comparing the efficacy and safety of 10day to 5day terlipressin treatment of bleeding esophageal varices.","volume":"56","author":"Bruha","year":"2009","journal-title":"Hepatogastroenterology"},{"key":"R14-28-20250312","doi-asserted-by":"crossref","first-page":"219226","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome.","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"key":"R15-28-20250312","doi-asserted-by":"crossref","first-page":"12751280","DOI":"10.1136\/gut.2008.165910","article-title":"Lowdose terlipressin plus banding ligation versus lowdose terlipressin alone in the prevention of very early rebleeding of oesophageal varices.","volume":"58","author":"Lo","year":"2009","journal-title":"Gut"},{"key":"R16-28-20250312","first-page":"617623","article-title":"Terlipressin vs octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized doubleblind placebocontrolled trial.","volume":"104","author":"Abid","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R17-28-20250312","doi-asserted-by":"crossref","first-page":"S1S21","DOI":"10.1016\/j.amjmed.2007.09.001","article-title":"Hyponatremia treatment guidelines 2007: expert panel recommendations.","volume":"120","author":"Verbalis","year":"2007","journal-title":"Am J Med"},{"key":"R19-28-20250312","first-page":"223226","article-title":"Hyponatremia and central pontine myelinolisis.","volume":"27","author":"Burcar","year":"1997","journal-title":"Neurology"},{"key":"R20-28-20250312","first-page":"14391441","article-title":"Pontine and extrapontine myelinolysis following rapid correction of hyponatremia.","volume":"i","author":"Laureno","year":"1998","journal-title":"Lancet"},{"key":"R21-28-20250312","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ajem.2008.10.012","article-title":"Extrapontine myelinolysis after correction of hyponatremia presenting as generalised tonic seizures.","volume":"27","author":"McNeill","year":"2009","journal-title":"Am J Emerg Med"},{"key":"R22-28-20250312","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/00365520701191849","article-title":"Terlipressin causing a hyponatremic seizure.","volume":"42","author":"Dunwoodie","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"R23-28-20250312","first-page":"518519","article-title":"Severe hyponatremia after repeated administration of terlipressin in French.","volume":"48","author":"Douriez","year":"1993","journal-title":"Therapie"},{"key":"R24-28-20250312","doi-asserted-by":"crossref","first-page":"14941508","DOI":"10.1111\/j.1742-1241.2009.02103.x","article-title":"Diagnosis and management of hyponatremia in hospitalised patients.","volume":"63","author":"Reddy","year":"2009","journal-title":"Intern J Clin Practice"},{"key":"R25-28-20250312","doi-asserted-by":"crossref","first-page":"10021010","DOI":"10.1002\/hep.22418","article-title":"Hyponatremia in cirrosis: pathognesis, clinical significance, and management.","volume":"48","author":"Gines","year":"2008","journal-title":"Hepatology"},{"key":"R26-28-20250312","doi-asserted-by":"crossref","first-page":"802810","DOI":"10.1002\/hep.1840400409","article-title":"Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.","volume":"40","author":"Heuman","year":"2004","journal-title":"Hepatology"},{"key":"R27-28-20250312","doi-asserted-by":"crossref","first-page":"11351143","DOI":"10.1053\/j.gastro.2006.02.017","article-title":"Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation.","volume":"130","author":"Londono","year":"2006","journal-title":"Gastroenterology"},{"key":"R28-28-20250312","doi-asserted-by":"crossref","first-page":"12831290","DOI":"10.1136\/gut.2006.102764","article-title":"MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.","volume":"56","author":"Londono","year":"2007","journal-title":"Gut"},{"key":"R29-28-20250312","doi-asserted-by":"crossref","first-page":"336343","DOI":"10.1002\/lt.20329","article-title":"Addition of serum sodium into the MELD scores predicts waiting list mortality better than MELD alone.","volume":"11","author":"Ruf","year":"2005","journal-title":"Liver Transpl"},{"key":"R30-28-20250312","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/hep.20517","article-title":"Serum sodium predicts mortality in patients listed for liver transplantation.","volume":"41","author":"Biggins","year":"2005","journal-title":"Hepatology"},{"key":"R31-28-20250312","doi-asserted-by":"crossref","first-page":"10181026","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver transplantation waiting list.","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.23893","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201011000-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T11:06:31Z","timestamp":1741777591000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201011000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.23893","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}